---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-269474"
form_type: "8-K"
ticker: "CNTA"
cik: "0001847903"
company_name: "Centessa Pharmaceuticals plc"
filed_at: "2026-06-12T20:15:32+00:00"
generated_at: "2026-06-12T20:31:38.811062+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Centessa shareholders approve Lilly acquisition; court sanction hearing June 22

## Summary
- Shareholders voted 126,653,456 for vs 23,007 against (99.98% of votes cast) to approve the scheme of arrangement.
- All seven shareholders of record voted in favor; no shareholder voted against.
- Court sanction hearing scheduled for June 22, 2026 at Royal Courts of Justice, London.
- Acquisition by Eli Lilly via court-sanctioned scheme expected to close following court approval.

## SEC filing metadata
- accession: 0001193125-26-269474
- form_type: 8-K
- ticker: CNTA
- cik: 0001847903
- company_name: Centessa Pharmaceuticals plc
- filed_at: 2026-06-12T20:15:32+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847903/000119312526269474/0001193125-26-269474-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847903/000119312526269474/d105373d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-269474
- JSON: https://secwatch.observer/filing/0001193125-26-269474.json
- Plain text: https://secwatch.observer/filing/0001193125-26-269474.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.